{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T17:38:19Z","timestamp":1791221899876,"version":"4.1.0"},"reference-count":34,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,10,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In 2012, new publications in the Journal described both the predictive value of the new IFN-\u03b3 release assays for diagnosis of latent tuberculosis (TB), but also provided evidence that these new tests cannot be interpreted simply as positive or negative, as initially hoped. Surgical masks can reduce transmission of TB infection, but other measures such as state-wide implementation of targeted testing and treatment of latent TB or active case finding require substantial and sustained effort to successfully reduce TB morbidity and mortality. A quasiexperimental study revealed that a package of social interventions could substantially reduce risk of TB disease in heavily exposed (and infected) children in the preantibiotic era. A study in a high-TB burden setting suggested that a new rapid drug-susceptibility test for TB may be more practical for implementation than traditional culture-based phenotypic tests. And two studies of TB vaccines revealed that currently used bacillus Calmette-Gu\u00e9rin strains vary in their ability to affect correlates of immunogenicity, whereas a new candidate vaccine, MVA85A, was safe and immunogenic in adults. Studies of nontuberculous mycobacteria (NTM) described a rapid rise in the prevalence and spatial clustering of NTM in the United States over the past decade. Although risk factors for pulmonary NTM such as advanced age and low BMI are known, the mechanisms underlying infection and disease remain mysterious. Four studies of therapy of NTM disease highlighted the pressing need for well-designed international randomized controlled trials to improve our management of NTM disease.<\/jats:p>","DOI":"10.1164\/rccm.201304-0687up","type":"journal-article","created":{"date-parts":[[2013,10,15]],"date-time":"2013-10-15T15:24:13Z","timestamp":1381850653000},"page":"923-927","source":"Crossref","is-referenced-by-count":23,"title":["Update in Tuberculosis and Nontuberculous Mycobacterial Disease 2012"],"prefix":"10.1093","volume":"188","author":[{"given":"Dick","family":"Menzies","sequence":"first","affiliation":[{"name":"Montreal Chest Institute, McGill University, Montreal, Canada; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Payam","family":"Nahid","sequence":"additional","affiliation":[{"name":"San Francisco General Hospital, at University of California, San Francisco, San Francisco, California"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2013,10,15]]},"reference":[{"key":"2026032100450539800_bib1","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1164\/rccm.201107-1198OC","article-title":"Differentiation and recruitment of IL-22-producing helper T cells stimulated by pleural mesothelial cells in tuberculous pleurisy","volume":"185","author":"Ye","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1164\/rccm.201110-1769OC","article-title":"Doxycycline and HIV infection suppress tuberculosis-induced matrix metalloproteinases","volume":"185","author":"Walker","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib3","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1164\/rccm.201201-0094OC","article-title":"Corticosteroid-modulated immune activation in the tuberculosis immune reconstitution inflammatory syndrome","volume":"186","author":"Meintjes","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib4","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1164\/rccm.201203-0444OC","article-title":"Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis","volume":"186","author":"Fennelly","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1164\/rccm.201107-1190OC","article-title":"Surgical face masks worn by patients with multidrug-resistant tuberculosis: impact on infectivity of air on a hospital ward","volume":"185","author":"Dharmadhikari","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib6","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1164\/rccm.201206-1134OC","article-title":"Predictive value of recent QuantiFERON conversation for tuberculosis disease in adolescents","volume":"186","author":"Machingaidze","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib7","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1164\/rccm.201106-1083OC","article-title":"Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study","volume":"185","author":"Zenner","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib8","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1164\/rccm.201201-0026OC","article-title":"Identifying predictors of interferon-\u03b3 release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study","volume":"186","author":"Basu Roy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1164\/rccm.201107-1244OC","article-title":"Discordance among commercially available diagnostics for latent tuberculosis infection","volume":"185","author":"Mancuso","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib10","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1164\/rccm.201107-1355OC","article-title":"CD8+ T cells provide an immunologic signature of tuberculosis in young children","volume":"185","author":"Lancioni","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib11","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1164\/rccm.201205-0960OC","article-title":"Genotype MTBDRsl line probe assay shortens time to diagnosis of extensively drug-resistant tuberculosis in a high-throughput diagnostic laboratory","volume":"186","author":"Barnard","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib12","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1126\/science.339.6116.130","article-title":"Infectious disease: approval of novel TB drug celebrated\u2014with restraint","volume":"339","author":"Cohen","year":"2013","journal-title":"Science"},{"key":"2026032100450539800_bib13","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1128\/AAC.06126-11","article-title":"Randomized pilot trial of eight weeks of bedaquiline (TMC207) treatment for multidrug-resistant tuberculosis: long-term outcome, tolerability, and effect on emergence of drug resistance","volume":"56","author":"Diacon","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"2026032100450539800_bib14","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1056\/NEJMoa0808427","article-title":"The diarylquinoline TMC207 for multidrug-resistant tuberculosis","volume":"360","author":"Diacon","year":"2009","journal-title":"N Engl J Med"},{"key":"2026032100450539800_bib15"},{"key":"2026032100450539800_bib16","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMoa1112433","article-title":"Delamanid for multidrug-resistant pulmonary tuberculosis","volume":"366","author":"Gler","year":"2012","journal-title":"N Engl J Med"},{"key":"2026032100450539800_bib17","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1164\/rccm.201111-2076OC","article-title":"Moving toward tuberculosis elimination: implementation of statewide targeted tuberculin testing in Tennessee","volume":"186","author":"Cain","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib18","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1164\/rccm.201201-0023OC","article-title":"Can social interventions prevent tuberculosis? The Papworth experiment (1918-1943) revisited","volume":"186","author":"Bhargava","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib19","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1164\/rccm.201111-1941OC","article-title":"Community-based targeted case finding for tuberculosis and HIV in household contacts of patients with tuberculosis in South Africa","volume":"185","author":"Shapiro","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1164\/rccm.201104-0714OC","article-title":"The influence of bacille Calmette-Guerin vaccine strain on the immune response against tuberculosis: a randomized trial","volume":"185","author":"Ritz","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib21","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1164\/rccm.201108-1548OC","article-title":"A phase IIa trial of the new tuberculosis vaccine, MVA85A, in HIV-and\/ormycobacterium","volume":"185","author":"Scriba","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib22","article-title":"Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial","author":"Tamerais","journal-title":"Lancet"},{"key":"2026032100450539800_bib23","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1164\/rccm.201205-0825OC","article-title":"Environment or host? A case-control study of risk factors for Mycobacterium avium complex lung disease","volume":"186","author":"Dirac","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib24","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1164\/rccm.201205-0913OC","article-title":"Spatial clusters of nontuberculous mycobacterial lung disease in the United States","volume":"186","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib25","first-page":"193","article-title":"Sensitivity to mycobacterial PPD antigens with some laboratory evidence of its significance","volume":"18","author":"Palmer","year":"1966","journal-title":"Tuberkuloza"},{"key":"2026032100450539800_bib26","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1164\/rccm.201107-1327OC","article-title":"Nontuberculous mycobacterial disease in patients with HIV in Southeast Asia","volume":"185","author":"McCarthy","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib27","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201111-2016OC","article-title":"Prevalence of nontuberculous mycobacterial lung disease in U.S. Medicare beneficiaries","volume":"185","author":"Adjemian","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib28","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1164\/rccm.201107-1203OC","article-title":"Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease","volume":"185","author":"Hayashi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib29","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1164\/rccm.201204-0682OC","article-title":"The pharmacokinetics and pharmacodynamics of pulmonary Mycobacterium avium complex disease treatment","volume":"186","author":"van Ingen","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib30","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1164\/rccm.201206-1088OC","article-title":"Therapeutic drug monitoring in the treatment of Mycobacterium avium complex lung disease","volume":"186","author":"Koh","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1164\/rccm.201111-2005OC","article-title":"Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance","volume":"186","author":"Choi","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib32","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1164\/rccm.201208-1478ED","article-title":"Treatment of pulmonary Mycobacterium avium complex infections: do drug levels matter?","volume":"186","author":"Schluger","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1164\/rccm.201208-1500ED","article-title":"Treatment of Mycobacterium abscessus: all macrolides are equal, but perhaps some are more equal than others","volume":"186","author":"Stout","year":"2012","journal-title":"Am J Respir Crit Care Med"},{"key":"2026032100450539800_bib34","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1164\/rccm.201207-1321ED","article-title":"Mycobacterium avium complex lung disease therapy","volume":"186","author":"Griffith","year":"2012","journal-title":"Am J Respir Crit Care Med"}],"container-title":["American Journal of Respiratory and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/8\/923\/67292129\/ajrccm_188_8_923.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajrccm\/article-pdf\/188\/8\/923\/67292129\/ajrccm_188_8_923.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T04:47:12Z","timestamp":1774068432000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajrccm\/article\/188\/8\/923\/8506692"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":34,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2013,10,15]]},"published-print":{"date-parts":[[2013,10,15]]}},"URL":"https:\/\/doi.org\/10.1164\/rccm.201304-0687up","relation":{},"ISSN":["1073-449X","1535-4970"],"issn-type":[{"value":"1073-449X","type":"print"},{"value":"1535-4970","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2013,10]]},"published":{"date-parts":[[2013,10]]}}}